Jim Moriarty

She needed ten hours of work for a high school science project. She gave it three hundred. By the time seventeen-year-old Anya Pogharian entered a clinical laboratory at Héma-Québec, she was no longer carrying an ordinary science-fair experiment. She was carrying a dialysis machine she had built herself. The device was called the Dialysave. The test was simple. A standard hospital dialysis machine could filter four liters of blood in roughly two and a half hours. Anya’s five-hundred-dollar prototype needed to prove it could do the same. Four liters. Real human blood. Clinical laboratory conditions. The Dialysave finished in twenty-five minutes. That was the moment everything changed. Anya’s invention had filtered the blood about six times faster than the hospital benchmark, using a machine that cost a fraction of the thirty-thousand-dollar systems commonly used in medical facilities. She had not begun with money, a research team, or a company. She had begun by watching patients. A year earlier, Anya volunteered inside a Montreal dialysis unit. She saw people sitting beside large machines as blood traveled out of their bodies, through filters, and back again. The treatment lasted hours. Patients returned several times each week. Afterward, many were too exhausted to do anything except go home and sleep. Their lives were arranged around the machine. Work. Family. Travel. Freedom. Everything depended on the next dialysis appointment. That was what stayed with Anya. She went home and began reading equipment manuals, engineering diagrams, and technical descriptions. She learned that dialysis machines used pumps, tubing, valves, filters, and electronic controls. Many of the parts were already commercially available. So she ordered them. Then she built a prototype on a workbench in her parents’ home. The first version cost approximately five hundred dollars. And it worked. Anya entered the project in science competitions and began receiving awards and attention. News of the low-cost machine spread quickly. Messages arrived from patients and families around the world. People wrote from countries where dialysis was too expensive, too distant, or unavailable. A medical company offered supplies. Héma-Québec offered Anya an internship and the opportunity to test the device in a professional laboratory. There, working with research director Louis Thibault, she refined the design and prepared for the decisive experiment. They hoped the Dialysave might match the hospital machine. They did not expect it to outperform it so dramatically. Twenty-five minutes. That result did not mean the machine was immediately ready for hospitals. Medical devices require years of safety testing, certification, funding, and regulatory approval. The Dialysave has not yet reached the large-scale use Anya imagined. But she proved something important. A teenager, working from home with affordable components, could challenge assumptions surrounding one of medicine’s most expensive machines. Anya did not spend three hundred hours because she wanted a better school grade. She did it because she had watched sick people lose entire days of their lives to treatment. She saw a machine everyone accepted as inevitable. Then she asked whether it could be faster, smaller, and affordable. The answer came from a laboratory filled with real human blood. Twenty-five minutes. Sometimes innovation begins when someone young enough to question everything refuses to accept that expensive and difficult must always mean necessary.